CDK8-IN-19

CAT: 0804-HY-176282Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-176282Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDK8-IN-19 (Compound 3d) is a CDK8 inhibitor with an IC50 of 25.08 nM. CDK8-IN-19 has a broad-spectrum anticancer activity, such as leukemia, melanoma and breast cancer, without significant cytotoxic effect on the normal Vero cells (mean IC50s of 2.87, 3.65, 3.79 and 45.48 μM, respectively) [1].
UNSPSC
12352005
Target
CDK; PI3K
Related Pathways
Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Field of Research
Cancer
Smiles
S=C(NC1=CC=C(Cl)C=C1Cl)NC(S/C2=C/C3=CC=CC=C3)=NC2=O
Molecular Formula
C17H11Cl2N3OS2
Molecular Weight
408.32
References & Citations
[1]Mohamed AR, et al. Integrated structure- and ligand-based design, synthesis, and biological evaluation of potent thiazole-based multi-kinase PI3Kα and CDK2/8 inhibitors as anticancer agents. Eur J Med Chem. 2025 Oct 15;296:117902.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2; CDK8; PI3Kα

Related Products

CatalogName
HY-158377CDK8/19-IN-2
HY-168846CDK8/19-IN-3
HY-111427-01CDK8/19-IN-1
HY-147716CDK8-IN-6
HY-111463-01CDK8-IN-3
HY-151463-01CDK8-IN-11
HY-103492-01CDK8-IN-1
HY-171174-01CDK8-IN-16
HY-162600CDK8-IN-15
HY-151371CDK8-IN-10

Alternative Products

CatalogName
MF-0117843-01CDK8-IN-19
BUP21189-01CDK8/19-IN-51
MF-0004902-01CDK8/19-IN-1
MF-0148017-01CDK8/19-IN-2
MF-0113440-01CDK8/19-IN-3
A19986-100CDK8/19-IN-1 100mg
A19857-1Anti-CDK8/19 Antibody
A19986-1CDK8/19-IN-1 1mg
A19986-10CDK8/19-IN-1 10mg
A19986-25CDK8/19-IN-1 25mg

Popular Products